Resveratrol is most commonly used for high cholesterol, cancer, heart disease, and many other conditions. However, there is not strong evidence to support the use of resveratrol for these uses. Resveratrol is available as dietary supplements from red wine extracts, grape seed extracts, and Japanese knotweed extracts, among others. Most supplements on the market are derived from Japanese knotweed because this plant has one of the highest concentrations of resveratrol found in nature. Resveratrol is also available in solution form and as a transdermal patch. Resveratrol is considered a dietary supplement and its safety and effectiveness have not been approved by the US Food and Drug Administration.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Resveratrol, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.